Naltrexone Hydrochloride/Bupropion Hydrochloride

盐酸纳曲酮/盐酸安非他酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNaltrexone Hydrochloride/Bupropion Hydrochloride
Drug Alias Name盐酸纳曲酮盐酸安非他酮Bupropion and NaltrexoneAmfebutamone hydrochloride/Naltrexone HydrochlorideBupropion Hydrochloride/Naltrexone HydrochlorideNaltrexone - bupropion mixt +[10] 
ClassificationSmall molecules
Mechanisms of ActionDopamine reuptake inhibitorsAdrenergic receptors antagonistsMu opioid receptor antagonists
TargetsDopamine transporterAdrenergic receptorsMu opioid receptor
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityBinge-Eating DisorderCognition +[7] 
Global Approved IndicationsOverweightObesity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2014/09/10
Country/TerritoryUnited StatesEU
CombinationsYes Bupropion HydrochlorideNaltrexone Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOrexigen
China Registration ClassN/A

Develop Information

Active CompaniesOrexigen Therapeutics Ireland LtdYale UniversityNalpropion Pharmaceuticals Inc +[5] 
Inactive CompaniesOrexigen Therapeutics IncUniversity Of California, Los Angeles
Active IndicationsBinge-Eating DisorderOverweightObesity +[4] 
Inactive IndicationsAttention Deficit Disorder with HyperactivityCognitionTobacco Use Disorder

Other Information

ATC CodeA08AA62
Related LinksWikipediaKEGG